Non-Hodgkin lymphoma among young adults with and without AIDS in Italy

International Journal of Cancer

Volumn 93, Issue 3, 2001, Pages 430-435

  Dal Maso, Luigino ^a   Rezza, Giovanni ^b   Zambon, Paola ^c   Tagliabue, Giovanna ^d   Crocetti, Emanuele ^e   Vercelli, Marina ^f   Zanetti, Roberto ^g   Falcini, Fabio ^h   Tonini, Giuseppe ⁱ   Mangone, Lucia ^j   De Lisi, Vincenzo ^k   Ferretti, Stefano ^l   Tumino, Rosario ^m   Stanta, Giorgio ⁿ   Vitarelli, Susanna ^o   Serraino, Diego ^p   Franceschi, Silvia ^q  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^h Ospedale Morgagni Pierantoni   (Italy)

ⁱ REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^j Registro Tumori di Modena   (Italy)

^k UNIVERSITY HOSPITAL OF PARMA   (Italy)

^l UNIVERSITY OF FERRARA   (Italy)

^m CIVILE M P AREZZO HOSPITAL   (Italy)

ⁿ C/o Ospedale S Santorio ^*  (Italy)

^o UNIVERSITY OF CAMERINO   (Italy)

^p NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^q INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

AIDS; Linkage; Non Hodgkin lymphoma

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; ITALY; LYMPHOBLASTOMA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; FEMALE; HUMANS; INCIDENCE; ITALY; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; PUBLIC HEALTH; REGISTRIES; RISK FACTORS; SURVIVAL RATE;

EID: 0035427183     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010801)93:3<430::AID-IJC1344>3.0.CO;2-K     Document Type: Article

References (27)

1. The rise in incidence of lymphomas in Europe 1985-1992
2. Advance in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms
3. Trends of AIDS incidence in Europe and the United States
4. HIV-related malignancies: Community-based study using linkage of cancer registry and HIV registry data
5. Cancer risk among men with or at risk of HIV infection in southern Europe
6. Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden
7. Spectrum of AIDS-associated malignant disorders
8. Linkage of AIDS and cancer registries in Italy
9. Risk of cancer in people with AIDS
10. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy
11. La notifica della mortalità per AIDS in Italia (1992): Qualità della certificazione e sottonotifica
12. Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States
13. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome
14. Non-Hodgkin's lymphoma. Application of the International Classification of Disease for Oncology (ICD-O) to the working formulation
15. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
16. Non-Hodgkin's lymphoma
17. Pathological and immunophenotypic features of adult non-Hodgkin's lymphomas by age group
18. Statistical methods in cancer research
19. Nonparametric estimation from incomplete observations
20. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS
21. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
22. The impact of highly active anti-retroviral therapy on the incidence of cancer in people infected with the human imnmnodeficiency virus. Collaborative reanalysis of individual data on 47,936 HIV-infected people from 23 cohort studies in 12 developed countries
23. HIV-associated non-Hodgkin's lymphoma: Highly active antiretroviral therapy improves remission rate of chemotherapy